Chances for Success of CavatermTM Surgery as a Function of Uterus Probe Length
NCT ID: NCT01436903
Last Updated: 2013-03-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
290 participants
INTERVENTIONAL
2010-09-30
2011-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
CavatermTM vs TCRE in Women With DUB
NCT00549159
Utilization of Uterine Manipulator in Abdominal Hysterectomy
NCT03943485
Impact of Uterine and Ovarian Vessel Occlusion on Blood Loss in High Burden Minimally Invasive Myomectomy.
NCT07182045
Hysteroscopic Cryomyolysis for the Treatment of Submucosal Leiomyomata
NCT00731341
Comparing Two Devices of Uterine Manipulation and Vaginal Fornix Delineation at Total Laparoscopic Hysterectomy
NCT02197728
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Thermal Balloon Endometrial Ablation
Thermal Balloon Endometrial Ablation for 10 minutes after curettage
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* timeframe: January 2006 till August 2009
* older than 29 years and younger than 56 years
Exclusion Criteria
* fragmentary filled questionnaire
* more than 1 CavatermTM operation
30 Years
55 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Vienna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Beda Hartmann
Univ.-Doz. Dr. Mag.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Beda W. Hartmann, Univ.-Doz.
Role: PRINCIPAL_INVESTIGATOR
Medical University of Vienna
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Landesklinikum Thermenregion Neunkirchen
Neunkirchen, Lower Austria, Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
743/2010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.